UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

Lung cancer (Amsterdam, Netherlands), 2019-07, Vol.133, p.83-87

2019

Volltextzugriff (PDF)

Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach

Allergy (Copenhagen), 2017-12, Vol.72 (12), p.1962-1971

2017

Volltextzugriff (PDF)

Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells

Annals of oncology, 2019-04, Vol.30, p.ii12-ii12

2019

Volltextzugriff (PDF)

Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis

Annals of oncology, 2019-04, Vol.30, p.ii35-ii35

2019

Volltextzugriff (PDF)

The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC

Annals of oncology, 2019-04, Vol.30, p.ii36-ii36

2019

Volltextzugriff (PDF)

A new PET-CT score for locally-advanced inoperable NSCLC stage III patients treated with chemoradiotherapy

Annals of oncology, 2019-04, Vol.30, p.ii37-ii37

2019

Volltextzugriff (PDF)

Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysis

European review for medical and pharmacological sciences, 2020-02, Vol.24 (4), p.1877

2020

Volltextzugriff (PDF)

Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy

Annals of oncology, 2019-04, Vol.30, p.ii11-ii11

2019

Volltextzugriff (PDF)

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation

ESMO open, 2023-08, Vol.8 (4), p.101587-101587, Article 101587

2023

Volltextzugriff (PDF)

Ultra-early response capturing in the treatment of non-squamous NSCLC using diffusion-weighted MRI: A prospective multicenter study

Annals of oncology, 2018-10, Vol.29, p.viii546-viii546

2018

Volltextzugriff (PDF)

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Annals of oncology, 2022-01, Vol.33 (1), p.67-79

2022

Volltextzugriff (PDF)

1309P Immune exhaustion in tumor-free lymph nodes of non-small cell lung cancer (NSCLC) patients is associated with performance status and survival

Annals of oncology, 2023-10, Vol.34, p.S752-S752

2023

Volltextzugriff (PDF)

115P Concurrent versus sequential immune checkpoint inhibition in stage III NSCLC patients treated with chemoradiation

Annals of oncology, 2022-04, Vol.33, p.S86

2022

Volltextzugriff (PDF)

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

AIDS (London), 2012-07, Vol.26 (12), p.F31-F37

2012

Volltextzugriff (PDF)

P63.03 Very Limited SCLC Benefits From Surgery and Adjuvant Chemotherapy – A Large Retrospective Analysis

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1183-S1183

2021

Volltextzugriff (PDF)

P47.11 COMPEL: Chemotherapy With/Without Osimertinib in Patients With EGFRm Advanced NSCLC and Progression on First-Line Osimertinib

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1101-S1101

2021

Volltextzugriff (PDF)

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

Retrovirology, 2012-09, Vol.9 (S2), p.P283-P283, Article P283

2012

Volltextzugriff (PDF)

Organ-cocultures (COCs) for Long Term in vitro Studies of Lung Cancer Using 2-Photon Microscopy

Technology in cancer research & treatment, 2011-06, Vol.10 (3), p.275-279

2011

Volltextzugriff (PDF)

PO-1029: Preliminary analysis of patient cohorts treated pre vs post approval of consolidation IO in LANSCLC

Radiotherapy and oncology, 2020-11, Vol.152, p.S548-S548

2020

Volltextzugriff (PDF)

1266P Interim analysis from the multicenter ROSE study: Radiation during osimertinib treatment safety and efficacy cohort

Annals of oncology, 2024-09, Vol.35, p.S810-S811

2024

Volltextzugriff (PDF)

EP08.01-057 Pembrolizumab Maintenance in Patients with Metastatic Squamous Non-Small Cell Lung Cancer (sNSCLC) - AIO-TRK-0115/PRIMUS

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S366-S367

2022

Volltextzugriff (PDF)

EP04.01-015 Lung Cancer after Solid Organ Transplantation - A Claims Data Analysis

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S252

2022

Volltextzugriff (PDF)

EP07.04-08 Immune Cell States as Predictors of Survival in Surgically Treated Stage I Non-small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S547

2023

Volltextzugriff (PDF)

PO-1166 Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients

Radiotherapy and oncology, 2021-08, Vol.161, p.S968-S968

2021

Volltextzugriff (PDF)

PO-1195 Residual MTV after chemoradiotherapy ± immune checkpoint inhibition for inoperable stage III NSCLC

Radiotherapy and oncology, 2021-08, Vol.161, p.S991-S991

2021

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Englisch
(218)
Deutsch
(26)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach

Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells

Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis

The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC

A new PET-CT score for locally-advanced inoperable NSCLC stage III patients treated with chemoradiotherapy

Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysis

Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation

Ultra-early response capturing in the treatment of non-squamous NSCLC using diffusion-weighted MRI: A prospective multicenter study

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

1309P Immune exhaustion in tumor-free lymph nodes of non-small cell lung cancer (NSCLC) patients is associated with performance status and survival

115P Concurrent versus sequential immune checkpoint inhibition in stage III NSCLC patients treated with chemoradiation

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

P63.03 Very Limited SCLC Benefits From Surgery and Adjuvant Chemotherapy – A Large Retrospective Analysis

P47.11 COMPEL: Chemotherapy With/Without Osimertinib in Patients With EGFRm Advanced NSCLC and Progression on First-Line Osimertinib

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

Organ-cocultures (COCs) for Long Term in vitro Studies of Lung Cancer Using 2-Photon Microscopy

PO-1029: Preliminary analysis of patient cohorts treated pre vs post approval of consolidation IO in LANSCLC

1266P Interim analysis from the multicenter ROSE study: Radiation during osimertinib treatment safety and efficacy cohort

EP08.01-057 Pembrolizumab Maintenance in Patients with Metastatic Squamous Non-Small Cell Lung Cancer (sNSCLC) - AIO-TRK-0115/PRIMUS

EP04.01-015 Lung Cancer after Solid Organ Transplantation - A Claims Data Analysis

EP07.04-08 Immune Cell States as Predictors of Survival in Surgically Treated Stage I Non-small Cell Lung Cancer (NSCLC)

PO-1166 Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients

PO-1195 Residual MTV after chemoradiotherapy ± immune checkpoint inhibition for inoperable stage III NSCLC

Suchergebnisse filtern